pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 371 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
Ofev
Ofev (nintedanib esylate)
Systemic Sclerosis (Scleroderma)
Boehringer Ingelheim Corp
4 catalysts
Marketed
ET-800
HYDROCORTISONE (hydrocortisone)
Adrenal Insufficiency
$ETONEton Pharmaceuticals, Inc.
3 catalysts
Marketed
Fluticasone Propionate Glenmark
Fluticasone Propionate (fluticasone propionate)
Non Allergic Rhinitis
Glenmark Pharmaceuticals Ltd
3 catalysts
← prev
page 2 of 13
next →
131
Pain89
Neurology1
Marketed
NEOSTIGMINE METHYLSULFATE
NEOSTIGMINE METHYLSULFATE (NEOSTIGMINE METHYLSULFATE)
Acetylcholinesterase
$AMPHAmphastar Pharmaceuticals, Inc.
3 catalysts
Marketed
PROGESTERONE
PROGESTERONE (PROGESTERONE)
Female Infertility
Progesterone receptor
IBSA Institut Biochimique SA
3 catalysts
Marketed
mycophenolate sodium DR
Mycophenolate Sodium (mycophenolate sodium)
Kidney Transplant Rejection
Wanbang Biopharmaceuticals Co Ltd
3 catalysts
Marketed
nerandomilast
Jascayd (nerandomilast)
Systemic Sclerosis (Scleroderma)
Boehringer Ingelheim International GmbH
3 catalysts
Marketed
rozanolixizumab
Rystiggo (rozanolixizumab-noli)
Myasthenia Gravis
UCB SA
3 catalysts
Marketed
voclosporin
Lupkynis (voclosporin)
Lupus Nephritis
$AUPHAurinia Pharmaceuticals Inc.
3 catalysts
Marketed
omalizumab biosimilar
Omlyclo (OMALIZUMAB-IGEC)
Food Allergy
Immunoglobulin heavy constant epsilon
Kashiv BioSciences LLC
2 catalysts
Marketed
BETAMETHASONE DIPROPIONATE
BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)
Inflammation
Perrigo New York Inc
1 catalysts
Phase 2
BW-20805
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Shanghai Argo Pharmaceutical Co Ltd
1 catalysts
Marketed
CEVIMELINE HYDROCHLORIDE
CEVIMELINE HYDROCHLORIDE (CEVIMELINE HYDROCHLORIDE)
Xerostomia
Zydus Therapeutics Inc
1 catalysts
Marketed
CLADRIBINE
CLADRIBINE (CLADRIBINE)
Relapsing Remitting Multiple Sclerosis (RRMS)
EMD Serono Inc
1 catalysts
Marketed
Clobetasol Propionate Teva
Clobetasol Propionate (clobetasol propionate)
Atopic Dermatitis (Atopic Eczema)
Teva Pharmaceuticals USA Inc
1 catalysts
Phase 1
HLK-0006
Anaphylaxis
Pharmacin BV
1 catalysts
Marketed
HYDROCORTISONE SODIUM SUCCINATE
HYDROCORTISONE SODIUM SUCCINATE (HYDROCORTISONE SODIUM SUCCINATE)
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease)
Cipla USA Inc
1 catalysts
Marketed
NAPROXEN
NAPROXEN (NAPROXEN)
Primary Dysmenorrhea
Hikma Pharmaceuticals USA Inc
1 catalysts
Marketed
PILOCARPINE HYDROCHLORIDE
PILOCARPINE HYDROCHLORIDE (PILOCARPINE HYDROCHLORIDE)
Xerostomia
Innogenix Inc
1 catalysts
Marketed
TAZAROTENE
TAZAROTENE (TAZAROTENE)
Idiopathic Pulmonary Fibrosis
Retinoic acid receptor
$GRIGRI Bio, Inc.
1 catalysts
Marketed
abatacept
Orencia (abatacept)
Graft Versus Host Disease (GVHD)
Bristol-Myers Squibb Co
1 catalysts
Marketed
canakinumab
Ilaris (canakinumab)
Familial Mediterranean Fever
$NVSNOVARTIS AG
1 catalysts
Marketed
danazol
Danazol (danazol)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
Lannett Co Inc
1 catalysts
Marketed
depemokimab
Exdensur (depemokimab-ulaa)
Nasal Polyps (Nasal Polyposis)
$GSKGSK plc
1 catalysts
Marketed
epinephrine bitartrate
EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (epinephrine bitartrate)
Anaphylaxis
De Motu Cordis Pty Ltd
1 catalysts
Marketed
icotrokinra hydrochloride
Icotyde (icotrokinra hydrochloride)
Ulcerative Colitis
$JNJJOHNSON & JOHNSON
1 catalysts
Marketed
sibeprenlimab
Voyxact (sibeprenlimab-szsi)
Sicca Syndrome (Sjogren)
Visterra Inc
1 catalysts
Phase 2
siplizumab
Vicalex (siplizumab)
Transplant Rejection
T-cell surface antigen CD2
ITB-Med AB
1 catalysts
Marketed
sulfasalazine DR
Sulfasalazine Greenstone (sulfasalazine)
Juvenile Rheumatoid Arthritis
Greenstone LLC
1 catalysts
Phase 3
telitacicept
telitacicept [INN]
Primary Sjogren's Syndrome
$VORVor Biopharma Inc.
1 catalysts